CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - PRELIMINARY-REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS

被引：11

作者：

BRAMWELL, VHC

MOURIDSEN, HT

SANTORO, A

BLACKLEDGE, G

SOMERS, R

THOMAS, D

SYLVESTER, R

VANOOSTEROM, A

机构：

[1] CHRISTIE HOSP & HOLT RADIUM INST,MANCHESTER M20 9BX,LANCS,ENGLAND

[2] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK

[3] IST NAZL TUMORI,I-20133 MILAN,ITALY

[4] QUEEN ELIZABETH HOSP,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND

[5] ANTONI VANLEEUWENHOEK HOSP,AMSTERDAM,NETHERLANDS

[6] EORTC DATA CTR,BRUSSELS,BELGIUM

[7] UNIV HOSP ANTWERP,DEPT CLIN ONCOL,EDEGEM,BELGIUM

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 18卷

关键词：

D O I：

10.1007/BF00647440

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S13 / S16

页数：4

共 22 条

[1]

ANTMAN KH, 1985, CANCER TREAT REP, V69, P499

[2]

BONADONNA G, 1982, CANCER CHEMOTHERAPY, V4, P373

[3]

BONADONNA G, 1984, CANCER CHEMOTHERAPY, V6, P436

[4]

BONADONNA G, 1983, CANCER CHEMOTHERAPY, V5, P430

[5] IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL [J].

BRADE, WP ;

HERDRICH, K ;

VARINI, M .

CANCER TREATMENT REVIEWS, 1985, 12 (01) :1-47

[6] CARMINOMYCIN VS ADRIAMYCIN IN ADVANCED SOFT-TISSUE SARCOMAS - AN EORTC RANDOMIZED PHASE-II STUDY [J].

BRAMWELL, VHC ;

MOURIDSEN, HT ;

MULDER, JH ;

SOMERS, R ;

VANOOSTEROM, AT ;

SANTORO, A ;

THOMAS, D ;

SYLVESTER, R ;

MARKHAM, D .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (08) :1097-1104

[7] COMBINED MODALITY MANAGEMENT OF LOCAL AND DISSEMINATED ADULT SOFT-TISSUE SARCOMAS - A REVIEW OF 257 CASES SEEN OVER 10 YEARS AT THE CHRISTIE-HOSPITAL-AND-HOLT-RADIUM-INSTITUTE, MANCHESTER [J].

BRAMWELL, VHC ;

CROWTHER, D ;

DEAKIN, DP ;

SWINDELL, R ;

HARRIS, M .

BRITISH JOURNAL OF CANCER, 1985, 51 (03) :301-318

[8]

BRAMWELL VHC, 1980, CANCER CHEMOTHERAPY, V2, P393

[9]

BRAMWELL VHC, 1981, CANCER CHEMOTHERAPY, V3, P409

[10]

BRAMWELL VHC, 1979, CANCER CHEMOTHERAPY, V1, P424

← 1 2 3 →